Confirmed lower risk of hypoglycaemia with insulin glargine versus NPH insulin:: a meta-analysis of 2304 patients with Type 2 diabetes.

被引:0
|
作者
Rosenstock, J
Benedetti, MM
Häring, HU
Lin, Z
Salzman, A
机构
[1] Med City Dallas, Dallas Diabet & Endocrine Ctr, Dallas, TX USA
[2] Univ Perugia, Dept Med Interna & Sci Endocrine & Metabol, I-06100 Perugia, Italy
[3] Med Universitatsklin, Tubingen, Germany
[4] Aventis Pharma, Bridgewater, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
879
引用
收藏
页码:A304 / A304
页数:1
相关论文
共 50 条
  • [1] Confirmed lower risk of hypoglycemia with insulin glargine versus NPH insulin:: A meta-analysis of 2304 patients with type 2 diabetes
    Rosenstock, J
    Benedetti, MM
    Häring, HU
    Salzman, A
    [J]. DIABETES, 2003, 52 : A454 - A454
  • [2] Lower severe hypoglycemia risk: Insulin glargine versus NPH insulin in type 2 diabetes
    Dailey, George
    Strange, Poul
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (01): : 25 - 30
  • [3] Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine
    Home, P. D.
    Fritsche, A.
    Schinzel, S.
    Massi-Benedetti, M.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (09): : 772 - 779
  • [4] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
    Dailey, G. E.
    Gao, L.
    Aurand, L.
    Garg, S. K.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
  • [5] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    [J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [6] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
    Dailey, G.
    Aurand, L.
    Garg, S.
    [J]. DIABETOLOGIA, 2011, 54 : S262 - S262
  • [7] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [8] Insulin glargine is associated with less hypoglycaemia than NPH insulin in older patients with Type 2 diabetes
    Riddle, M
    Massi-Benedetti, M
    Häring, HU
    Dailey, G
    Murray, F
    Lin, Z
    Rosenstock, J
    [J]. DIABETOLOGIA, 2004, 47 : A328 - A328
  • [9] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients
    Fritsche, A
    Dailey, G
    Lin, Z
    Murray, F
    Häring, H
    Rosenstock, J
    [J]. GERONTOLOGIST, 2004, 44 : 221 - 221
  • [10] A meta-analysis of phase III/IIIb studies comparing insulin glargine with human NPH insulin in Type 2 diabetes: severe hypoglycaemia is less common with insulin glargine.
    Dailey, G
    Riddle, M
    Benedetti, MM
    Fritsche, A
    Lin, Z
    Salzman, A
    [J]. DIABETOLOGIA, 2003, 46 : A305 - A305